-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk
Prepared … Implementation Guide: Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk. … Patient self-care/family caregivers as part of self-assessment or health maintenance:
Mr. … Items specific to the Updated risk assessment:
9. … Calculation of a baseline 10-Year ASCVD risk assessment score.
2.
-
cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared
August 22, 2017 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-baseline-10
February 01, 2018 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-updated-10
August 22, 2017 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - 30 – 3:30 PM ET
AGENDA
· Welcome
· Discuss Remaining Repository Questions
· Clarify 10-Year Risk Assessment … Clarify 10-Year Risk Assessment Details
Evaluation of the patient record to appropriately identify risk … assessment variables/data elements
CAMH requested the WG members’ feedback on details related to the … currently under discussion with the proposed pilot site, and the artifacts tested will focus on CVD risk assessment
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/NIOSH_Occupational%20Factors%20Impacting%20Diabetes_Decision%20Log_condensed.pdf
February 01, 2018 - provider team
“relevant features” Characteristics determined to be included in an occupational factor
assessment … environment determined to impact diabetes
management (determined to be included in an occupational factor
assessment … text, it is included in
the NIOSH flow diagram and should be included in the occupational factors
assessment … It displays a warning
message if at least one of the factor’s last assessment date is greater than 6
-
cds.ahrq.gov/sites/default/files/cds/artifact/106/AMIA_presentation.pptx
January 01, 2012 - and < 95th %tile)
16.9% of all children are considered obese (BMI ≥ 95th %tile)
We conducted a needs assessment … Prev Chronic Dis 2012;9:120118
3
Childhood Obesity at CHOP:
Needs Assessment Findings
Strong clinician … would need to account for multiple workflows
Many strong divergent opinions collected during the needs assessment
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
December 01, 2018 - Ideally, a LOINC
code would be used to represent
each assessment, their individual
questions, … result ranges
(Intervention
logic)
Assessment tool authors often
include an interpretation … Implementation Decision: Add
assessment score ranges to the
logic. … Wong-Baker
FACES
Assessment
(Intervention
logic)
This assessment usually supports
pain intensity … However, OCHIN provides
the assessment with a scale of 0–5.
-
cds.ahrq.gov/sites/default/files/cds/artifact/127731/ASPIRE_ExerciseGuidanceForFallPrevention_Flow_0.pdf
July 18, 2023 - Yes
NoPatients 65+ Not qualified for
recommendation
Yes
No
Fall Risk Assessment
Resulted with At
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
January 01, 2020 - meet Section
508 accessibility
requirements
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … Value Set
Updates
Documentation
Updates
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … The CDS community often cites challenges with
implementation and assessment of the impact of CDS. … Identified Pain Management Resources
5.1 Patient-Centered Pain Assessment
5.2 Opioid Avoidance
5.3 … Identified Pain Management CDS Efforts
6.1 Patient-Centered Pain Assessment
6.2 Opioid Avoidance
6.3
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2022.pdf
January 01, 2022 - year
N/A Postponed
until next
year
Yes
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … Shared Decision
Making
Retired N/A N/A Yes
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … https://cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared … https://cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared … https://cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
July 23, 2024 - making
▪ Provides an opportunity to identify errors in the patient record
▪ May shed new light on how assessment … Morphine Milligram Equivalent (MME)
– Flag if result is greater than or equal to 50: “Most recent MME assessment … most recent MME is greater than or equal to 50: “Absence
of Naloxone medication and most recent MME assessment
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
January 01, 2021 - CVD and Colorectal
Cancer
No N/A No Yes
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … Baseline 10-
Year ASCVD Risk
No N/A Yes Yes
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … for Shared
Decision Making
No N/A No Yes
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … https://cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared … https://cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - Patient’s pain assessment data, including the name of the assessment tool, the
score, and the date of … the assessment. … Note that the assessment tools expressed in
this artifact are those that were implemented in the pilot … tool, and assessment dates for the past year.
6. … ” Category heading in the summary that groups together pain intensity and multidimensional
assessment
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDS%20Pain%20Management%20Summary%20Quick%20Start%20Guide_final_1.pdf
July 23, 2024 - CDS Repository Working Group Charter
CDS Pain Management Summary Quick Start Guide
The Pain Management Summary displays relevant patient-centered data to inform pain management decisions.
It includes concepts outlined in the CDC Guideline for Prescribing Opioids for Chronic Pain.
To View the Pain Man…
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - i.e., coded) version of the 2013 PCE,
entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … Concept Definition and/or Rationale
Inclusions “Within the past 6
years”
The ACC/AHA recommends assessment … Because lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS
Connect … resource that is publicly available in the CDS Connect Million Hearts
Model Longitudinal ASCVD Risk Assessment … CMS’s Million Hearts® Model Longitudinal ASCVD Risk
Assessment Tool for Baseline 10-Year ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - i.e., coded) version of the 2013 PCE,
entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … supplemented by enabling data collection directly from the patient through an
automated form, risk assessment … Inclusions “Within the past 6 years” The ACC/AHA recommends assessment of ASCVD risk every four to six … Because lipid profile results and
smoking status are inputs to ASCVD risk assessment, the CDS Connect … CMS’s Million Hearts® Model Longitudinal ASCVD Risk
Assessment Tool for Baseline 10-Year ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - structured (i.e., coded) version of the PCE entitled CMS’s Million
Hearts® Model Longitudinal ASCVD Risk Assessment … supplemented by enabling data collection directly from the patient through an
automated form, risk assessment … Concept Definition and/or Rationale
Inclusions “Within the past 6
years”
The ACC/AHA recommends assessment … Because
lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS Connect … CMS’s Million Hearts® Model Longitudinal ASCVD Risk
Assessment Tool for Baseline 10-Year ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin%20and%20NSAIDs%20V.8.pdf
September 08, 2020 - Warfarin & NSAIDs
Warfarin
And
Oral NSAIDs
Is patient on proton
pump inhibitor or
misoprostol?
And
Yes No
Assess risk and take
action if necessary
Possible increased risk
of bleeding Is patient able
to start on
appropriate
proton pump
inhibitor?
Yes
Start patient on proton
pump inhibit…
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/CQL%20to%20CDS%20Hooks%20cards_0.txt
January 01, 2023 - Mapping of CQL conditions to CDS Hooks cards
Condition: NoDDimerNoWells
Card: It is recommended to assess the patient's risk for pulmonary embolism (PE) and evaluate D-dimer levels before proceeding with a CTPA order. Use the following link to evaluate the risk.
Launch Questionnaire: Yes
Condition: NoDDimerWellsLessT…